SEC Form 4 · accession 0000899243-16-026746
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curtis Hecht
Officer — VP, BUS. & CORP. DEVELOPMENT
Period of report
Aug 8, 2016
Accepted (ET)
Aug 10, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 8, 2016 | J | 3,085 | $0.00 | A | 14,210 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction represents pro rata distribution by DNA Ink, of which the reporting person is a limited partner.
- F2Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on May 13, 2016.